(Q35736662)

10 August 2017

1 reference

title

Cell-based therapies for Parkinson disease—past insights and future potential (English)

1 reference

10 August 2017

1 reference

3

Malin Parmar

1 reference

10 August 2017

1

Roger A Barker

1 reference

10 August 2017

author name string

Janelle Drouin-Ouellet

series ordinal

2

1 reference

10 August 2017

language of work or name

English

0 references

publication date

4 August 2015

1 reference

10 August 2017

published in

Nature Reviews Neurology

1 reference

10 August 2017

volume

11

1 reference

10 August 2017

issue

9

1 reference

10 August 2017

page(s)

492-503

1 reference

https://scigraph.springernature.com/pub.10.1038/nrneurol.2015.123

10 August 2017

exact match

0 references

cites work

Alpha-synuclein in Lewy bodies

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Staging of brain pathology related to sporadic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

The pharmacology of L-DOPA-induced dyskinesia in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Brain tissue transplanted to the anterior chamber of the eye: 2. Fluorescence histochemistry of immature catecholamine and 5-hydroxytryptamine neurons innervating the rat vas deferens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Development and growth of immature monoamine neurons in rat and manin situ and following intraocular transplantation in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

The biology and behaviour of intracerebral adrenal transplants in animals and man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

6-hydroxy-dopamine induced degeneration of central monoamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Neural grafting in Parkinson's disease Problems and possibilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Transplantation of adrenal medullary tissue to striatum in parkinsonism. First clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Intracerebral adrenal medulla grafts: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Open microsurgical autograft of adrenal medulla to the right caudate nucleus in two patients with intractable Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Adrenal medullary transplantation to the caudate nucleus in Parkinson's disease. Initial clinical results in 18 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Multicenter study of autologous adrenal medullary transplantation to the corpus striatum in patients with advanced Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Adrenal medullary transplant to the striatum of patients with advanced Parkinson's disease: 1-year motor and psychomotor data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Transplantation in Parkinson's disease: two cases of adrenal medullary grafts to the putamen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Neuropsychological effects of brain autograft of adrenal medullary tissue for the treatment of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

United Parkinson Foundation Neurotransplantation Registry on adrenal medullary transplants: presurgical, and 1- and 2-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Neuropathological study 16 years after autologous adrenal medullary transplantation in a Parkinson's disease patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Putative chromaffin cell survival and enhanced host-derived TH-Fiber innervation following a functional adrenal medulla autograft for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Adrenal to caudate transplantation--postmortem study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. A detailed account of methodology and a 6-month follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Long-term clinical outcome of fetal cell transplantation for Parkinson disease: two case reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Enhancement of survival of stored dopaminergic cells and promotion of graft survival by exposure of human fetal nigral tissue to glial cell line--derived neurotrophic factor in patients with Parkinson's disease. Report of two cases and technical con

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Simultaneous intrastriatal and intranigral fetal dopaminergic grafts in patients with Parkinson disease: a pilot study. Report of three cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Transplantation of embryonic dopamine neurons for severe Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Deep brain stimulation of the internal segment of the globus pallidus in delayed runaway dyskinesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Deep brain stimulation in Parkinson's disease following fetal nigral transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Dyskinesia after fetal cell transplantation for parkinsonism: a PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Graft-induced dyskinesias in Parkinson's disease: what is it all about?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Serotonergic neurons mediate dyskinesia side effects in Parkinson's patients with neural transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Graft-induced dyskinesias in Parkinson's disease: High striatal serotonin/dopamine transporter ratio.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

The impact of graft size on the development of dyskinesia following intrastriatal grafting of embryonic dopamine neurons in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Continuous exposure to glial cell line-derived neurotrophic factor to mature dopaminergic transplants impairs the graft's ability to improve spontaneous motor behavior in parkinsonian rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Dopamine cell implantation in Parkinson's disease: long-term clinical and (18)F-FDOPA PET outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Fetal dopaminergic transplantation trials and the future of neural grafting in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Factors affecting the clinical outcome after neural transplantation in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Autotransplantation of human carotid body cell aggregates for treatment of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Carotid body autotransplantation in Parkinson disease: a clinical and positron emission tomography study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Implantation of Spheramine in advanced Parkinson's disease (PD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Intrastriatal implantation of human retinal pigment epithelial cells attached to microcarriers in advanced Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Spheramine for treatment of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Efficient expansion and dopaminergic differentiation of human fetal ventral midbrain neural stem cells by midbrain morphogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Scientific and ethical issues related to stem cell research and interventions in neurodegenerative disorders of the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Developing stem cell therapies for Parkinson's disease: waiting until the time is right.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Embryonic stem cell lines derived from human blastocysts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Neural progenitors from human embryonic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

In vitro differentiation of transplantable neural precursors from human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

In vitro and in vivo analyses of human embryonic stem cell-derived dopamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Derivation of midbrain dopamine neurons from human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Enhanced yield of neuroepithelial precursors and midbrain-like dopaminergic neurons from human embryonic stem cells using the bone morphogenic protein antagonist noggin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Dopaminergic differentiation of human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Differentiation of human ES and Parkinson's disease iPS cells into ventral midbrain dopaminergic neurons requires a high activity form of SHH, FGF8a and specific regionalization by retinoic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Directed differentiation of dopaminergic neuronal subtypes from human embryonic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Human embryonic stem cell-derived dopaminergic neurons reverse functional deficit in parkinsonian rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Induction of pluripotent stem cells from fibroblast cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Identification of midbrain floor plate radial glia-like cells as dopaminergic progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Differences in neurogenic potential in floor plate cells along an anteroposterior location: midbrain dopaminergic neurons originate from mesencephalic floor plate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

The floor plate: multiple cells, multiple signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

How to make a midbrain dopaminergic neuron

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Pluripotent stem cells in regenerative medicine: challenges and recent progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Efficient derivation of functional floor plate tissue from human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Generation of regionally specified neural progenitors and functional neurons from human embryonic stem cells under defined conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Human ESC-derived dopamine neurons show similar preclinical efficacy and potency to fetal neurons when grafted in a rat model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Optogenetics enables functional analysis of human embryonic stem cell-derived grafts in a Parkinson's disease model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Survival and functional restoration of human fetal ventral mesencephalon following transplantation in a rat model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Geron gets green light for human trial of ES cell-derived product.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Tumorigenicity studies of induced pluripotent stem cell (iPSC)-derived retinal pigment epithelium (RPE) for the treatment of age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Lewy body pathology in fetal grafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Characterization of Lewy body pathology in 12- and 16-year-old intrastriatal mesencephalic grafts surviving in a patient with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Long-term health of dopaminergic neuron transplants in Parkinson's disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Fetal-cell revival for Parkinson's

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Does adrenal graft enhance recovery of dopaminergic neurons in Parkinson's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Autopsy findings in a patient who had an adrenal-to-brain transplant for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Autologous transplantation of adrenal medulla in Parkinson's disease. 18-month results

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Successful function of autologous iPSC-derived dopamine neurons following transplantation in a non-human primate model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

In vitro generation and transplantation of precursor-derived human dopamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Direct generation of functional dopaminergic neurons from mouse and human fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Direct conversion of human fibroblasts to dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

The therapeutic potential of human multipotent mesenchymal stromal cells combined with pharmacologically active microcarriers transplanted in hemi-parkinsonian rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Transplanted adrenal chromaffin cells in rat brain reduce lesion-induced rotational behaviour

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Functional reactivation of the deafferented neostriatum by nigral transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Brain tissue transplanted to the anterior chamber of the eye. 1. Fluorescence histochemistry of immature catecholamine and 5-hydroxytryptamine neurons reinnervating the rat iris.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Correlation of apomorphine- and amphetamine-induced turning with nigrostriatal dopamine content in unilateral 6-hydroxydopamine lesioned rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Restoration of dopaminergic function by grafting of fetal rat substantia nigra to the caudate nucleus: long-term behavioral, biochemical, and histochemical studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Reinnervation of the denervated striatum by substantia nigra transplants: functional consequences as revealed by pharmacological and sensorimotor testing

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Parkinson's disease--a new therapy?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Adrenal medullary tissue transplants in the caudate nucleus of Parkinson's patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Clinical, biochemical, and neuropathologic findings following transplantation of adrenal medulla to the caudate nucleus for treatment of Parkinson's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Adrenal medullary autografts in patients with Parkinson's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Adrenal medullary autograft transplantation into the striatum of patients with Parkinson's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Postmortem analysis of adrenal-medulla-to-caudate autograft in a patient with Parkinson's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Delayed recovery of movement-related cortical function in Parkinson's disease after striatal dopaminergic grafts

31 March 2020

2 references

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

31 March 2020

12 December 2020

NIH neural transplantation funding

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Dyskinesias following neural transplantation in Parkinson's disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Functional fetal nigral grafts in a patient with Parkinson's disease: chemoanatomic, ultrastructural, and metabolic studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Neural Tissue Xenotransplantation: What Is Needed Prior to Clinical Trials in Parkinson's Disease?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Xenotransplantation of porcine fetal ventral mesencephalon in a rat model of Parkinson's disease: functional recovery and graft morphology.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Intrastriatal transplantation of microcarrier-bound human retinal pigment epithelial cells versus sham surgery in patients with advanced Parkinson's disease: a double-blind, randomised, controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Transplantation of human embryonic stem cell-derived cells to a rat model of Parkinson's disease: effect of in vitro differentiation on graft survival and teratoma formation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Monosynaptic Tracing using Modified Rabies Virus Reveals Early and Extensive Circuit Integration of Human Embryonic Stem Cell-Derived Neurons

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Intrastriatal transplantation of mouse bone marrow-derived stem cells improves motor behavior in a mouse model of Parkinson's disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.123

Transplantation of dopamine-containing tissues to the central nervous system.

31 March 2020

1 reference

12 December 2020

Survival of human induced pluripotent stem cell-derived midbrain dopaminergic neurons in the brain of a primate model of Parkinson's disease.

1 reference

12 December 2020

Thalamic, pallidal, or subthalamic surgery for Parkinson's disease?

1 reference

12 December 2020

Behavioral, physiological, and neurochemical changes after 6-hydroxydopamine-induced degeneration of the nigro-striatal dopamine neurons

1 reference

12 December 2020

1 reference

12 December 2020

Cellular replacement of dopamine deficit in Parkinson's disease using human fetal mesencephalic tissue: preliminary results in four patients.

1 reference

12 December 2020

Dopamine agonists, receptor selectivity and dyskinesia induction in Parkinson's disease

1 reference

12 December 2020

Intracerebral grafting of neuronal cell suspensions. II. Survival and growth of nigral cell suspensions implanted in different brain sites.

1 reference

12 December 2020

Study of adrenal medullary tissue transplantation to striatum in parkinsonism

1 reference

12 December 2020

Stereotaxic intrastriatal implantation of human retinal pigment epithelial (hRPE) cells attached to gelatin microcarriers: a potential new cell therapy for Parkinson's disease

1 reference

12 December 2020

Brain Grafts Reduce Motor Abnormalities Produced by Destruction of Nigrostriatal Dopamine System

1 reference

12 December 2020

Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers

1 reference

12 December 2020

Neural tissue xenotransplantation: what is needed prior to clinical trials in Parkinson's disease? Neural Tissue Xenografting Project

1 reference

12 December 2020

10.1038/NRNEUROL.2015.123

Identifiers

DOI

1 reference

10 August 2017

1 reference